Procter & Gamble Health Ltd

P & G Health Ltd | 500126

Live

₹6,839.00

+₹226.80 (+3.43%)

As on 10/07/26, 4:13 PM

Market Cap10,975.51 CR

Current Price₹6,839

High / Low₹6,765 / 4,707

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE58.14%

Face Value₹2.00

Current Vol.82,938

Average Vol.---

ISININE199A01012

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Share Price Chart - Procter & Gamble Health Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹6,612₹6,615.5

₹6,839

Previous CloseToday's Open

₹4,707₹6,765

₹6,839

52W Low52W High

₹6,615.5Today's Open

₹6,612Previous Close

82,938Volume

₹4,70752W Low

₹6,76552W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations
Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals
The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products
The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products
They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs
The company operates in two business divisions, namely Pharmaceuticals and Chemicals

Ethics: Procter & Gamble Health Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI70.09

SMA 206297.27

SMA 505875.63

SMA 1005427.60

SMA 2005631.18

SMA 106343.80

MACD_12_26_Days137.27

EMA10Day6355.17

EMA20Day6266.88

EMA50Day5957.95

MACD_12_26_9_Days-13.64

EMA100Day5716.07

EMA200Day5629.73

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	44,711	₹4,106.95	697.41%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	44,711	₹4,106.95	697.41%
ISHARES INDIA SC MAURITIUS COMPANY	03 Oct ‘22	Sell	6,405	₹4,106.95	99.91%
ISHARES MSCI INDIA SMALL-CAP ETF	03 Oct ‘22	Purchase	6,405	₹4,106.95	99.91%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

12 Feb 2026

Interim Dividend (₹110)

Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2025-26 of Rs. 160 per Equity Share (including a one-time special dividend of Rs. 50 per Equity Share). The dividend shall be paid on or before March 4, 2026.

06 Feb 2026

12 Feb 2026

Special Dividend (₹50)

The Board has declared an Interim Dividend for the Financial Year 2025-26 of Rs. 160 per Equity Share (including a one time special dividend of Rs. 50 per Equity Share). The dividend shall be paid on or before March 4, 2026

06 Feb 2026

29 Aug 2025

AGM

06 Aug 2025

22 Aug 2025

Final Dividend (₹45)

We are pleased to inform you that a meeting of the Board of Directors of the Company held today (commenced at 12.40 pm and ended at 5.14 pm), We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a dividend of Rs. 45 per Equity Share, for the Financial Year ended March 31, 2025. The divided shall be paid on or before September 25, 2025, on approval of the Members at the ensuing Annual General Meeting

29 May 2025

21 Feb 2025

Interim Dividend (₹80)

Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2024-25 of Rs. 80 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before March 7, 2025.

12 Feb 2025

05 Dec 2024

AGM

22 Aug 2024

29 Nov 2024

Final Dividend (₹60)

Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs. 60 per equity share, for the financial year ended June 30, 2024. The dividend shall be paid by December 25, 2024, on approval of the Members at the 57th Annual General Meeting. We would like to inform that the Register of Members and Share transfer books shall remain closed from November 29, 2024 to December 5, 2024 for the purpose of Annual General Meeting and payment of dividend for the Financial Year 2023-24, if approved by the shareholders of the Company at their 57th Annual General Meeting to be held on December 5, 2024. The notice of the Annual General Meeting will be shared in the due course. (As Per BSE Announcement dated on 22.08.2024)

21 Aug 2024

14 Feb 2024

Interim Dividend (₹50)

Inter alia, have declared an Interim Dividend for the Financial Year 2023-24 of Rs.200/- (including one-time special dividend of Rs. 150) per Equity Share having face value of Rs. 10/- each. The dividend shall be paid on or before March 3, 2024.

06 Feb 2024

14 Feb 2024

Special Dividend (₹150)

06 Feb 2024

30 Nov 2023

AGM

24 Aug 2023

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
6,622			0
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 135 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Procter & Gamble Health Ltd?

The current share price of Procter & Gamble Health Ltd (P & G Health Ltd) is ₹6839.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd has a 52-week high of ₹6765.00 and a 52-week low of ₹4707.00. This range shows the stock's price volatility over the past year.

What is the ROE of Procter & Gamble Health Ltd?

Procter & Gamble Health Ltd has a Return on Equity (ROE) of 58.14%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video